Alih, Alfiesar A.
HRN: 18-80-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/02/2024
07/09/2024
400 MG
IV
Q6
PCAP-B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes